Swiss - Delayed Quote CHF
Xlife Sciences AG (XLS.SW)
19.75
0.00
(0.00%)
As of 1:51:40 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-421.51
-421.51
171.78
-4,607.48
-4,324.08
Investing Cash Flow
-3,998.50
-3,998.50
-1,014.10
-1,684.91
-7,033.34
Financing Cash Flow
4,298.03
4,298.03
828.55
4,556.30
8,595.33
End Cash Position
99.03
99.03
218.71
221.04
1,956.35
Capital Expenditure
-12.09
-12.09
-41.08
-80.16
-1,212.04
Issuance of Capital Stock
0
0
105.73
5,012.47
9,359.45
Issuance of Debt
4,406.93
4,406.93
841.72
--
--
Free Cash Flow
-433.60
-433.60
130.70
-4,687.63
-5,536.12
12/31/2021 - 2/11/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BSLN.SW Basilea Pharmaceutica AG
50.60
+0.40%
XBIT XBiotech Inc.
2.9400
+1.38%
SANN.SW Santhera Pharmaceuticals Holding AG
13.28
-4.18%
IDIA.SW Idorsia Ltd
1.9920
-1.14%
CLSD Clearside Biomedical, Inc.
0.7610
-3.24%
TECH Bio-Techne Corporation
49.88
+2.44%
CRBP Corbus Pharmaceuticals Holdings, Inc.
9.21
-0.22%
BLRX BioLineRx Ltd.
5.93
+3.31%
RCKT Rocket Pharmaceuticals, Inc.
3.0200
-1.47%
CTXR Citius Pharmaceuticals, Inc.
1.3700
+60.99%